Infection

SEP 4, 2026 · PHASE 1 TRIAL

NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

ClinicalTrials.gov

Phase 1 study of an mRNA-based cell therapy in chronic granulomatous disease with feasibility and safety as primary outcomes; no results reported in this registry record.

SEP 1, 2026 · OBSERVATIONAL STUDY

Plasma Neprilysin for Predicting Sepsis Within 48 Hours in ICU Patients With Infection or Suspected Infection

ClinicalTrials.gov

This is an ongoing observational registry study with no results reported; it is designed to explore whether plasma neprilysin predicts sepsis development within 48 hours in ICU patients.

AUG 18, 2026 · PHASE 4 TRIAL

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

ClinicalTrials.gov

This is a recruiting Phase 4 interventional trial with no results posted; the registry record describes only the planned design and safety endpoints, not outcomes.

AUG 7, 2026 · OBSERVATIONAL STUDY

Early Sepsis Recognition Tool

ClinicalTrials.gov

This is an active observational registry study with no posted results; it describes planned enrollment and outcome measures for sepsis recognition tool validation across Asian pediatric sites.

AUG 5, 2026 · JOURNAL ARTICLE

An explainable machine learning model for predicting in-hospital infection in patients with systemic lupus erythematosus.

Renal Failure

A machine learning model development study using retrospective electronic health records with internal validation but no external prospective validation, no clinical outcome trial, and no demonstration of impact on clinical decision-making or patient outcomes.